Provider review
Noom Med review
An explicit microdose track, bundled inside a coaching subscription.
Medication, visits and coaching are one subscription price, so the medication cost is never broken out.
Price as published
From $79 first 4 weeks, then $199/mo (12-week subscription) — meds, visits, and support bundled
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The verdict
Noom runs an explicit microdose track pairing a clinician evaluation with its coaching app, and it leans on FDA-approved branded products where they are available — which is a meaningfully different risk profile from the compounded majority of this board. The cost is bundled: medication, clinical visits and coaching arrive as one subscription, so you cannot see what the medication itself costs, and the recurring rate after the intro period is above the cheapest flat options here. A branded-product focus also means insurance dependence and availability that shifts.
The trade-off we would want you to read first
Higher recurring cost than CoreAge's flat $79–$129 once the intro period ends
Who it suits, and who it does not
A good fit if
- You want behavioural coaching as a real part of the programme, not an add-on
- You prefer FDA-approved branded products where they can be obtained
- You want one subscription rather than several line items to track
Look elsewhere if
- You want to know what the medication alone costs
- You are comparing on the lowest ongoing monthly rate
- You need availability that does not move with brand supply and insurance
How the programme works
Noom's Microdose GLP-1Rx track pairs an expert-clinician evaluation with its coaching app. Noom leans on FDA-approved branded products (Wegovy/Ozempic, Zepbound/Mounjaro) and may prescribe compounded versions where appropriate. The bundle folds medication, clinical visits, and coaching into one subscription price.
At a glance
- Pricing structure
- Varies by dose, plan or tier
- Consult
- Included in the price
- Compounding
- Network
- Labs
- Optional
- Dietitian support
- Not included
Strengths
- Explicit microdose track with clinician evaluation and behavioral coaching built in
- Leans on FDA-approved branded products where available, plus FSA/HSA eligibility
The other trade-offs
- Coaching-subscription bundle, so the medication cost is not broken out transparently
- Branded-product focus can mean insurance dependence and shifting availability
Before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Where this sits on the board
Noom Med is one of 24 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Funding & disclosures
- A number of links are affiliate or referral links.
- Begin treatment through one and we may earn a commission via the Katalys network — at no added cost to you.
- What we write about a provider is the same either way — unflattering findings about one that pays us stay in.
- Full detail: disclosure page.